CITU blames lack of safety audits for recurrent accidents at pharma units
Mr. Narasinga Rao, while addressing the media on Wednesday, recalled the accident occurred at Escientia Pharma in Atchutapuram near Visakhapatnam last year, which claimed 17 lives. 'During the last one year, 32 persons have lost their lives in 11 accidents at pharma units in Anakapalli district,' he said.
The gas leak from the LG Polymers plant in Visakhapatnam in the past had claimed 15 lives. He alleged that the negligence of the management was responsible for those accidents.
'However, neither the Centre nor the State had punished the erring management. On the contrary, LG Polymers was given the red carpet to set up its plant in Sri City of Tirupati district. Though pharma companies are in the red category list, the mandatory inspections were ignored on the pretext of Ease of Doing Business (EODB) and Speed of Doing Business (SODB),' Mr. Narasinga Rao said.
He alleged that inspections were not being conducted by the officials concerned even after complaints related to violations of laws were lodged. 'Inspections are being done only after approval from Delhi,' he said and sought to know why AI could not be utilised to prevent industrial accidents.
He alleged that the use of outdated equipment and the reuse of recovered solvents were the main causes for reactor blasts.
'The governments are washing their hands off after payment of ex gratia. A super speciality hospital with a burns unit should be available close to pharma industries. The Burns Unit, which was available in Visakhapatnam Steel Plant (VSP), was closed,' he pointed out.
He said that it was unfortunate that the governments, which were evincing keen interest in the establishment of pharma companies, were not bothered about the safety of workers. The lack of rest, enrolment of unskilled workers, in areas which require high proficiency, were the other causes contributing to accidents.
CITU district president KM Srinivas, and Pharma City Staff and Workers Union president Ganisetty Satyanarayana were present.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Economic Times
9 hours ago
- Economic Times
FerTech startup Luma Fertility raises $4 million from Peak XV's Surge fund, others
Mumbai-based fertility-tech startup Luma Fertility has raised $4 million in a round led by Peak XV's Surge platform, which provides seed funding to startups. The round also saw Ameera Shah, executive chairperson of diagnostic company Metropolis Healthcare, and Vijay Taparia, chairman of venture capital firm B2V Ventures, participate. Luma Fertility will use the funds to open more full-stack fertility clinics in Mumbai and expand to other cities over the next two years. 'From my own experience and after speaking to hundreds of women, it became clear that fertility care in India is broken. It's optimised for systems, not people. At Luma, we've rebuilt it from the ground up—designed entirely around the patient,' said Neha K Motwani, the startup's founder, in a prepared statement. Motwani had earlier built fitness marketplace Fitternity, which was acquired by in 2021. Currently, the company has a 6,000 sq ft flagship clinic located in Mumbai's Bandra West. The clinic offers services such as in-vitro fertilisation (IVF), egg and embryo freezing, fertility assessments, and pre-conception consultations. It also has an AI-enabled tool, LumaAI, to assist patients.'Fertility care in India is at an inflection point. Demand is growing rapidly, but the system is deeply fragmented and outdated,' Metropolis Healthcare's Shah said in a statement.B2V Ventures' Taparia, added, 'Having backed Neha in her earlier venture, I've seen firsthand her ability to build with conviction and scale with integrity. Moreover, there is a clear need for consumer-first healthcare in India, especially in single-specialty verticals like fertility.'
Time of India
10 hours ago
- Time of India
FerTech startup Luma Fertility raises $4 million from Peak XV's Surge fund, others
Mumbai-based fertility-tech startup Luma Fertility has raised $4 million in a round led by Peak XV's Surge platform, which provides seed funding to round also saw Ameera Shah, executive chairperson of diagnostic company Metropolis Healthcare , and Vijay Taparia, chairman of venture capital firm B2V Ventures, Fertility will use the funds to open more full-stack fertility clinics in Mumbai and expand to other cities over the next two years.'From my own experience and after speaking to hundreds of women, it became clear that fertility care in India is broken. It's optimised for systems, not people. At Luma, we've rebuilt it from the ground up—designed entirely around the patient,' said Neha K Motwani, the startup's founder, in a prepared statement. Motwani had earlier built fitness marketplace Fitternity, which was acquired by in the company has a 6,000 sq ft flagship clinic located in Mumbai's Bandra West. The clinic offers services such as in-vitro fertilisation (IVF), egg and embryo freezing, fertility assessments, and pre-conception consultations. It also has an AI-enabled tool, LumaAI, to assist patients.'Fertility care in India is at an inflection point. Demand is growing rapidly, but the system is deeply fragmented and outdated,' Metropolis Healthcare's Shah said in a statement.B2V Ventures' Taparia, added, 'Having backed Neha in her earlier venture, I've seen firsthand her ability to build with conviction and scale with integrity. Moreover, there is a clear need for consumer-first healthcare in India, especially in single-specialty verticals like fertility.'
The Hindu
14 hours ago
- The Hindu
CITU blames lack of safety audits for recurrent accidents at pharma units
Expressing concern over the death of 40 people in the reactor blast at a pharma company near Hyderabad, CITU State general secretary Ch. Narasinga Rao has blamed callousness by factory managements and lack of safety audits for the recurring accidents in pharma companies. Mr. Narasinga Rao, while addressing the media on Wednesday, recalled the accident occurred at Escientia Pharma in Atchutapuram near Visakhapatnam last year, which claimed 17 lives. 'During the last one year, 32 persons have lost their lives in 11 accidents at pharma units in Anakapalli district,' he said. The gas leak from the LG Polymers plant in Visakhapatnam in the past had claimed 15 lives. He alleged that the negligence of the management was responsible for those accidents. 'However, neither the Centre nor the State had punished the erring management. On the contrary, LG Polymers was given the red carpet to set up its plant in Sri City of Tirupati district. Though pharma companies are in the red category list, the mandatory inspections were ignored on the pretext of Ease of Doing Business (EODB) and Speed of Doing Business (SODB),' Mr. Narasinga Rao said. He alleged that inspections were not being conducted by the officials concerned even after complaints related to violations of laws were lodged. 'Inspections are being done only after approval from Delhi,' he said and sought to know why AI could not be utilised to prevent industrial accidents. He alleged that the use of outdated equipment and the reuse of recovered solvents were the main causes for reactor blasts. 'The governments are washing their hands off after payment of ex gratia. A super speciality hospital with a burns unit should be available close to pharma industries. The Burns Unit, which was available in Visakhapatnam Steel Plant (VSP), was closed,' he pointed out. He said that it was unfortunate that the governments, which were evincing keen interest in the establishment of pharma companies, were not bothered about the safety of workers. The lack of rest, enrolment of unskilled workers, in areas which require high proficiency, were the other causes contributing to accidents. CITU district president KM Srinivas, and Pharma City Staff and Workers Union president Ganisetty Satyanarayana were present.
